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Abstract: A multimodal approach for hydrogel-based nanoparticles 
was developed to selectively allow molecular conjugated species to 
either be released inside the cell or remain connected to the polymer 
network. Using the intrinsic difference in reactivity between esters and 
amides, nanogels with an amide-conjugated dye could be tracked 
intracellularly localizing next to the nucleus, while ester-conjugation 
allowed for liberation of the molecular species from the hydrogel 
network inside the cell, enabling delivery throughout the cytoplasm. 
The release was a result of particle exposure to the intracellular 
environment. The conjugation approach and polymer network building 
rely on the same chemistry and provide a diverse range of possibilities 
to be used in nanomedicine and theranostic approaches. 
Within the field of nanomedicine, delivery vehicles are regarded 
as one of the major strategies to successfully protect and deliver 
pharmaceutical components.[1] However, it also becomes more 
apparent that different delivery strategies are needed for different 
diseases and different cell types.[2] In drug delivery, both the 
release mechanism and the body distribution of the vehicle play 
an important role. Theranostic approaches, that combine 
diagnosis and treatment of disease, serve to visualize drug 
delivery vehicles.[2–4] So far, many of the theranostic approaches 
are performed with solid nanoparticles (inorganic/organic) or 
liposomes/polymersomes.[2–5] A major advantage of liposomes 
and polymersomes is that these allow the use of the complete 
particle volume for drug loading, while for most of the solid 
particles only the particle surface is available. However, solid 
structures have generally an enhanced stability towards different 
(bio)chemical environments, solvents, and mechanical stress. 
Hydrogel nanoparticles fulfill an important niche by combining 
high drug loading capacity with tunable stability and resilience. 
They consist of a covalent polymer network which provides the 
stability to cope with chemical environments and solvent 
compositions, and can be designed to respond to various stimuli 
such as temperature, pH, and light.[6] On top of that, hydrogel 
nanoparticles can undergo high deformations without breaking.[7]  
Hydrogel nanoparticles or nanogels, have been used in various 
fields of research including catalysis,[8,9] selective diagnostics and 
delivery,[10,11] and anti-fouling coatings[12,13]. Even though, these 
nanogels have found their way into the biomedical field,[14,15] 
theranostics and multimodalities remain underdeveloped and 
mostly hybrid structures are being used (inorganic/organic).[16–18] 
Few examples have been developed that rely solely on hydrogel 
structures[17,19–23] and when doing so, the multimodality originates 
from a single molecular species[24], which limits the general 
applicability. Therefore, creating a more generalized approach 
based on the same chemistry but with the possibility of easy 
exchanging the active structure provides a powerful approach and 
further develop the field of multimodal nanogels in nanomedicine. 
Our aim was to utilize the intrinsic difference in reactivity between 
ester- and amide-conjugation to tune the susceptibility of nanogel 
hydrolysis towards the intracellular environment and thereby 
controlling selective release of incorporated molecular structures. 
Esterases, found intracellular, are known to have chemical 
selectivity.25 The modalities with different intracellular stability 
were incorporated without altering the overall development of the 
nanogel and using acrylic esters, release of incorporated 
molecules was triggered within the cell while outside the cell 
release did not occur. Using acrylamide conjugation, release was 
absent both outside and inside the cell, and particle tracking was 
facilitated. Intracellular stability of the nanogels was corroborated 
by the response of the nanogels toward cell lysate, which 
triggered similar release profiles. The presented versatile and 
innovative approach will trigger development of new multimodal 
particles for drug delivery and theranostics and exemplifies easy 
diversification using simple chemical approaches and introducing 
these within the same particle without affecting their function. 
The nanogel formation is based on well-established precipitation 
polymerization (Scheme 1).[25] The initiation of a free radical 
polymerization leads to small oligomers that have different 
solubility than the used monomers under set conditions, which 
leads to the precipitation and formation of small colloids. These 
colloids will grow in size and after termination of the 
polymerization reaction and reestablishment of solubilizing 
conditions of the polymers, the network within the colloids will be 
rehydrated, resulting in a nanogel. By using a mixture of 
monomers, various functionalities can be introduced such as 
degradability, responsiveness (temperature, pH, light, redox 
reactions), simply by adding other monomers that will take part in 
the polymerization process.[25] Here Fluorescein-acrylate (FL-Ac) 
and Nile Blue acrylamide (NB-AAm) have been used to 
demonstrate the principle of using the specific intracellular 
environment to selectively release or retain components in the 
nanogel, respectively (Figure S1). N-isopropylmethacrylamide 
(NIPMAM) is used as the responsive unit that facilitates the use 
of precipitation polymerization. The volume phase transition 
temperature (VPTT) of NIPMAM is around 45°C and above this 
temperature, dehydration occurs followed by precipitation and 
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provide a shell with a different composition around the initially 
formed core particle.[26,27] After the formation of the FL and NB-
labeled core particles, a shell consisting of NIPMAM, BIS, and 3-
acrylamidophenylboronic acid (APBA) was formed (Scheme 1) 
which was evaluated by 1H-NMR spectroscopy (Figure S2). It is 
know that APBA is enhancing cellular uptake in cancer cells, due 
to its ability to bind to the overexpressed sialic acid on the surface 
of cancer cells.[28–30] The difference in extracellular and 
intracellular reactivity as well as the intrinsic stability difference 
between esters and amides facilitate control over the release of 
incorporated molecules from the nanogel at the desired location 
(intracellular). After uptake of nanogels by cells via endocytosis, 
it was envisioned that there would be a fast release of ester-
conjugated structures from the nanogel due to the presence of 
esterases in endosomes, whereas the amide-conjugated 
structures will remain associated with the nanogel as illustrated in 
Scheme 1 and Figure S1. 
 
Scheme 1. Synthetic approach for the multimodal nanogels via controlled 
precipitation polymerization in a two-step fashion to create the core and 
subsequently the cell recognizing shell. Below a schematic representation of the 
overall behavior of release and tracking outside and within the cell. 
The nanogels used are primarily based on NIPMAM, which will 
dehydrate upon increasing the temperature to above the VPTT of 
45°C, which induces a decrease in size as shown by the 
temperature dependent dynamic light scattering (DLS) 
measurements (Figure S3A). The VPTT is far above 37°C, i.e., 
body temperature, at which cell cultures are primarily done. 
Clearly, similar handling and incubation temperatures will apply in 
a clinical setting. At these conditions, temperature-induced 
changes in the nanogels are not desired, as our aim is to elucidate 
the release profiles of the nanogels in response to the intracellular 
environment. Additionally, a collapsed matrix of the nanogel 
would inhibit proper exposure of the FL-Ac nanogel to the 
intracellular esterase and could inhibit the hydrolysis. At room 
temperature (20 °C) the hydrodynamic diameter for NB-AAm 
nanogel was 460 nm while at 37°C the diameter reduced slightly 
to 430 nm. For the FL-Ac nanogel the difference in hydrodynamic 
diameter was negligible, both around 300 nm (Figure S3A). The 
diameter of both nanogels decreased upon increasing the 
temperature far above 37°C and is therefore not considered to 
have any influence on cellular uptake or release events. The 
transmission electron microscopy (TEM) images confirm the 
presence of particle structures (Figure S3B/C). The diameters 
were approximately 320 nm for the NB-AAm nanogel and 200 nm 
for FL-Ac nanogel, which are slightly smaller than the 
hydrodynamic diameters in the swollen state observed by using 
DLS as the nanogels are in dry state when measured with TEM. 
It was envisioned that the intrinsic difference in reactivity of ester- 
and amide-conjugated structures could be utilized to control the 
release profile of nanogels following their exposure to the 
intracellular environment. Intracellular esterases are capable of 
hydrolyzing a variety of substrates, while amidases are more 
selective toward specific peptide bonds.[31] After nanogel 
internalization by cells, the difference in enzymatic susceptibility 
is utilized to initiate a release of ester-conjugated structures, here 
a Fluorescein-ester conjugated moiety, whereas amide-
conjugated structures, here a Nile Blue-amide conjugated moiety, 
remain confined to the nanogel. 
Confocal laser scanning microscopy (CLSM) of MCF-7 breast 
cancer cells incubated with NB-AAm nanogel for 2 hours revealed 
a punctate fluorescent pattern in the cell cytosol, suggesting the 
presence of nanogels in endosomes (Figure 1A). Incubation of 
MCF-7 cells with FL-Ac nanogel showed in addition to fluorescent 
spots, a diffuse cytosolic fluorescence. In addition, reticular 
structures were visible next to the nucleus, reminiscent of 
endoplasmic reticulum (Figure 1A). Clearly, the two types of 
nanogels displayed distinct intracellular distributions following 
their incubation with MCF-7 cells. To exclude that the intracellular 
distribution differences were a result of differences in nanogel 
cytotoxicity, a cell viability assay was performed. Both types of 
nanogels were identified to be non-toxic at the concentrations 
used within the experiments (Figure S4). The internalization of the 
nanogels rather than being confined to the surface of the cells 
was confirmed analyzing the fluorescence signal in the z-direction 
(Figure S5), which shows that the fluorescent signal is present 
within the cells. 
Next, MCF-7 cells were incubated with a mixture of NB-AAm and 
FL-Ac nanogels. Figure 1B shows that both nanogels were 
efficiently internalized by the cells, to a similar extent as upon 
separate incubations with the nanogels. Furthermore, MCF-7 
cells showed a partial overlap of Fluorescein spots with Nile Blue 
punctate in the cell cytosol, which most likely indicates 
colocalization of the fluorescent nanogels within endosomal 
structures (Figures 1B/S6). In addition, the fluorescein label was 
widely distributed over the entire cell. This highly diffuse pattern 
of the FL-Ac label indicates that the dye was efficiently cleaved 
from the nanogel, most likely due to the presence of endosomal 
esterases, and released from endosomes. Typically, esterases 
have a broader range of substrate acceptance for hydrolysis than 
amidases. Therefore, the NB-AAm label remained associated 
with the nanogel and confined to endosomes. Herewith, we show 
a simple approach to trigger intracellular cargo release or enable 
cargo confinement, by means of an intrinsic difference in reactivity 
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Figure 1 Representative confocal images of MCF-7 breast cancer cells treated with (A) FL-Ac nanogel and NB-AAm nanogel, separately, (B) a mixture of FL-Ac 
and NB-AAm nanogels, for 2 hours. Nile Blue (red) is present as distinct dots within the cell cytosol. Fluorescein (green) mainly shows a diffuse cytosolic localization. 
In addition, it is visible as reticular structures next to the nucleus, reminiscent of endoplasmic reticulum. Amplified images (bottom row) further demonstrate that the 
ester-conjugated Fluorescein (green) shows partial overlap with the distinct dots presented by the amide-conjugated Nile Blue (red). In addition, the ester-conjugated 
Fluorescein (green) shows a diffuse pattern throughout the cell. 
While the selectivity was illustrated using a mixture of the 
nanogels, for theranostic and/or dual drug delivery approaches, 
both properties should be incorporated into the same nanogel 
without affecting the individual characteristics. Therefore, a 
nanogel was prepared containing both the ester- and amide-
conjugated dyes and the same intracellular release study was 
performed, which also excludes the possibility that the differences 
in fluorescence patterns observed for the two types of nanogels 
are caused by differences in their size (Figure S3). Figure 2 shows 
the same distinct patterns for Fluorescein and Nile Blue as was 
observed from mixing the two nanogels, only now both originate 
from the same nanogel. The fluorescence signal from the ester-
conjugated Fluorescein is found both punctuated and cytosolic 
while the signal from the amide-conjugated Nile Blue is 
exclusively punctuated. This conceptual approach illustrates the 
delivery potential combined with traceability of such nanogels. 
 
Figure 2. Representative confocal image of MCF-7 breast cancer cells treated 
with Fl-NB-nanogels for 2 hours. Nile Blue (red) is present as distinct dots within 
the cell cytosol while Fluorescein (green) is present as dots and shows a diffuse 
distribution in the cell cytosol. 
Uptake of nanoparticles by cells primarily occurs via endocytosis. 
If nanogels are internalized via the endosomal pathway, then 
hydrolysis could also be facilitated by the lowering in pH. It is well 
known that the pH within an endosome decreases to pH value of 
6.5 for early endosomes and continues to be lowered to 5.5 for 
late endosomes and 4.5 for lysosomes.[32] This lowering of pH 
enhances the hydrolysis of esters. In order to identify if FL-Ac 
release from the nanogels is dependent on a drop in (endosomal) 
pH, we exposed the different nanogels to cell lysate at pH ~7. The 
cell lysate contains all enzymes found intracellularly, without the 
need of going through the uptake process. Thereby, the pH shifts 
at the different endosomal stages are omitted. After exposure of 
the nanogels to cell lysate and subsequently removing the 
nanogels via ultracentrifugation (Figure S7), the fluorescence 
signal of the supernatant was determined in order to analyze the 
release of fluorescent cargo from the nanogels. Fluorescence that 
was released from nanogels exposed to water served as a control. 
Figure S7 shows the absence of fluorescence signal in the 
supernatant of NB-AAm nanogels exposed to cell lysate, which 
was identical to that of the nanogel not exposed to cell lysate. In 
sharp contrast, the FL-Ac nanogel supernatant did not show 
fluorescence signal after exposure to water (Figure 3) while in the 
presence of HBSS buffer, a small fluorescence signal was 
detected. However, when in presence of cell lysate, the 
fluorescence intensity at the maximum wavelength (λmax = 518 
nm) is 13 times higher as compared to HBSS buffer alone, 
showing the substantial influence of the intracellular environment 
on the release. As the pH within these experiments was 
maintained at ~7, we can conclude that cell lysate components, 
presumably esterases, are able to selectively hydrolyze the FL-
Ac conjugates. These data were supported by bafilomycin A1 
inhibition experiments. MCF-7 cells were treated with nanogels in 
the absence and presence of bafilomycin A1, which inhibits the 
acidification of endosomes. As shown in Figure S8, the FL-Ac 
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bafilomycin A1 as in its absence, indicating that the FL-Ac can be 
released from the nanogel and redistributed throughout the cell 
without exposure to low pH. 
 
Figure 3. Fluorescence emission spectra of the supernatants of the ester-
conjugated (FL-Ac) nanogels after exposure to water, HBSS buffer, and HBSS 
buffer with cell lysate and subsequent removal of the nanogels via centrifugation 
to illustrate the release properties specific to the intracellular environment.  
We show that the difference in intracellular reactivity between 
esters and amides provides a powerful tool to decide between 
intracellular cargo release and confinement in nanogels. 
Controlled release may serve to mediate drug delivery, while 
confined cargo, e.g. fluorescence, can be used for nanogel 
tracking. In the field of theranostics, it is pertinent that different 
functions have tailored conjugation behavior. Tracer and drug 
release is thereby tunable and the approach opens up new 
possibilities for designing multimodal hydrogel nanoparticles for 
medical applications. More diverse chemistries are still to be 
explored, but it has already been shown that tuning the shape 
(linear vs. branched) and hydrophobicity of aliphatic esters 
resulted in differences in release rate in solid acrylate-based 
nanoparticles.[33] By diversifying the ester-conjugation in terms of 
hydrophobicity and steric hindrance, sequential release 
approaches would be possible from the same particle while 
maintaining the detection capabilities of using the amide-
conjugation. In short, hydrogel nanoparticles, so-called nanogels, 
find their way into biomedical applications because of the 
possibility of loading the entire particle volume with (therapeutic 
and/or diagnostic) substances [21], the diverse range of chemical 
components that can be included, as well as the ease of formation 
and upscaling. Introducing the multimodal approach as depicted 
here, these particles will become even more widely applicable. 
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Nanogels are highly versatile hydrogel nanoparticles that have much potential in nanomedicine and theranostics. The key issue 
remains to control the location of release of active conjugated moieties and controlling when and if conjugated structures will be 
liberated. Here a versatile approach is presented that allows selective intracellular release of small molecules that would 
tremendously affect the field of nanomedicine.  
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